Home › Compare › STAOF vs ABBV
STAOF yields 5714.29% · ABBV yields 3.06%● Live data
📍 STAOF pulled ahead of the other in Year 1
Combined, STAOF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STAOF + ABBV for your $10,000?
Sing Tao News Corporation Limited publishes and distributes newspapers, magazines, and books to readers in the People's Republic of China, North America, Australia, and Europe. The company publishes Chinese and English newspapers; and magazines that primarily focuses on current affairs and entertainment, lifestyle, and trends. It also publishes books in various categories, including parenting, travel, health, self-improvement, lifestyle, and culture. In addition, the company offers a multi-media platform for recruitment advertising under the JobMarket, HeadlineJobs.hk, and The StandardJobs titles. Further, it sells and distributes repackaged information and digital content created by its various media businesses, as well as third party content providers; and engages in the radio broadcasting, printing, securities trading and investment, and software development activities. Additionally, the company engages in the property holding activities; distribution of print-media publications; and operation of a Website. Sing Tao News Corporation Limited was founded in 1938 and is headquartered in Tseung Kwan O, Hong Kong.
Full STAOF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.